
Organization · Venture Capital
One Six 8 Ventures
One Six 8 Ventures is a Calgary-based venture capital firm specializing in early-stage investments in the MedTech sector. The firm focuses on high-growth areas such as AI-MedTech and remote patient monitoring, particularly in underserved regions.
Overview
What One Six 8 Ventures does
What One Six 8 Ventures is
One Six 8 Ventures is a Calgary-based venture capital firm specializing in early-stage investments in the MedTech sector. The firm focuses on high-growth areas such as AI-MedTech and remote patient monitoring, particularly in underserved regions.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- May 1, 2026
Official channels
Find One Six 8 Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
One Six 8 Ventures as a funder
Investment thesis
One Six 8 Ventures focuses on early-stage MedTech companies, particularly in underfunded regions like Canada, leveraging operator expertise to address critical healthcare needs and create strategic value.
Focus narrative
The fund specializes in early-stage investments in the MedTech sector, particularly in high-growth areas such as AI-MedTech, surgical tools and robotics, and remote patient monitoring. One Six 8 Ventures targets companies in underfunded regions, especially Canada, to uncover unique investment opportunities that demonstrate technological differentiation and clear pathways to commercialization.
Value beyond capital
One Six 8 Ventures provides active operational support from experienced operators and executives who have successfully scaled VC-backed MedTech and life-science companies. The firm emphasizes collaboration with portfolio companies to enhance their technical foundations, regulatory awareness, and commercialization pathways, ultimately positioning them for strategic exits.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series A+
- Sectors
- HealthcareArtificial IntelligenceRobotics & Autonomous SystemsDigital HealthBiotech & Life Sciences
- Regions
- North America · Global
Availability
- Currently deploying
- Not published
Portfolio and track record
Portfolio context
Fluid Biomed: Developing a hybrid polymer-metal flow-diverting stent aimed at curing brain aneurysms, enhancing vessel healing and post-operative visualization. PulseMedica: Creating a non-invasive, image-guided laser platform for treating eye floaters and other vitreoretinal diseases, integrating advanced laser technology with machine learning. Respiree: Offering an end-to-end cardio-pulmonary platform for remote care, utilizing wearable sensors and AI for real-time clinical monitoring and chronic disease management.
Connected ecosystem
Continue from One Six 8 Ventures
These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.
Same organization type
Structured sector focus
Structured regional focus
Common questions
What to know about One Six 8 Ventures
Upseed classifies One Six 8 Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 1, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.